Wu Yibing joined Temasek in October 2013. He currently serves as Joint Head of Technology & Consumer, Head of Enterprise Development Group (China) and President of China. He previously served as Joint Head of Portfolio Strategy & Risk Group. Mr. Wu was previously President of CITIC Private Equity Funds Management, a position he held since December 2009. He concurrently served as Chairman and Chief Executive Officer of Goldstone Investment Co. Ltd., the direct investment arm of CITIC Securities. He has over 27 years of investment and management experience, and held various senior management positions in major firms including McKinsey & Co, Lenovo Group, and Legend Holdings. Since Nov 2019, Mr. Wu has been Board Member of Gavi, the Vaccine Alliances, also serves on the board of China Social Entrepreneur Foundation. Mr. Wu holds a Doctor of Philosophy degree (PhD) in Biochemistry from Harvard University and a Bachelor of Science degree (BSc.) in Molecular Biology from University of Science and Technology of China.